Cormorant Private Healthcare Fund III LP, 10% Owner at Ambrx Biopharma Inc. (AMAM), bought 5,195,792 shares at $9.16 ($50.6M) on 2023-04-13, disclosed to the SEC on 2023-04-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.16 | 1,193,808 | $10.9M | 21.6% |
| 2 | $9.16 | 1,193,808 | $10.9M | 21.6% |
| 3 | $9.96 | 841,967 | $8.4M | 16.6% |
| 4 | $9.96 | 841,967 | $8.4M | 16.6% |
| 5 | $10.67 | 562,121 | $6.0M | 11.8% |
| 6 | $10.67 | 562,121 |
| $6.0M |
| 11.8% |
| Total | $9.75 avg | 5,195,792 | $50.6M | 100% |
| Filing → |
| AMAM | BUY | 2023-03-16 | $10.2M | — | Filing → |